Borrelia burgdorferi peptidoglycan as a diagnostic and target for therapeutic intervention of Lyme disease-related pathologies
US-12535481-B2 · Jan 27, 2026 · US
This page is not indexed by search engines while we improve data quality.
Virginia Tech Intellectual Properties Inc — Cross-Sectional Technologies
Virginia Tech Intellectual Properties Inc holds 124 patents in Cross-Sectional Technologies, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Virginia Tech Intellectual Properties Inc |
| Technology | Cross-Sectional Technologies |
| Patents in slice | 124 |
| Recent patents in slice | 38 |
| First year | 2016 |
| Last year | 2026 |
Representative patents
Notable publications linking Virginia Tech Intellectual Properties Inc to Cross-Sectional Technologies.
Mesoporous polyimide thin films as dendrite-suppressing separators for alkali metal batteries
US-2025367613-A1 · Dec 4, 2025 · US
Plasmonic nanoparticle layers with controlled orientation
US-2025327971-A1 · Oct 23, 2025 · US
Plasmonic nanoparticle layers with controlled orientation
US-2025327971-A1 · Oct 23, 2025 · US
Plasmonic nanoparticle layers with controlled orientation
US-2025327971-A1 · Oct 23, 2025 · US
Recent filings
Latest patents from Virginia Tech Intellectual Properties Inc in Cross-Sectional Technologies.
Borrelia burgdorferi peptidoglycan as a diagnostic and target for therapeutic intervention of Lyme disease-related pathologies
US-12535481-B2 · Jan 27, 2026 · US
Mesoporous polyimide thin films as dendrite-suppressing separators for alkali metal batteries
US-2025367613-A1 · Dec 4, 2025 · US
Plasmonic nanoparticle layers with controlled orientation
US-2025327971-A1 · Oct 23, 2025 · US
Plasmonic nanoparticle layers with controlled orientation
US-2025327971-A1 · Oct 23, 2025 · US
Plasmonic nanoparticle layers with controlled orientation
US-2025327971-A1 · Oct 23, 2025 · US
Related pages
Navigate to parent entity pages.